Search

Your search keyword '"Sokoll, Lori J."' showing total 198 results

Search Constraints

Start Over You searched for: Author "Sokoll, Lori J." Remove constraint Author: "Sokoll, Lori J." Search Limiters Full Text Remove constraint Search Limiters: Full Text
198 results on '"Sokoll, Lori J."'

Search Results

1. Validation of the novel GLAS algorithm as an aid in the detection of liver fibrosis and cirrhosis based on GP73, LG2m, age, and sex

3. The Prostate Health Index Selectively Identifies Clinically Significant Prostate Cancer

10. Additional file 1 of VCAM-1 complements CA-125 in detecting recurrent ovarian cancer

13. Proteogenomic characterization of pancreatic ductal adenocarcinoma

18. Proteogenomic and metabolomic characterization of human glioblastoma

19. Proteogenomic insights into the biology and treatment of HPV-negative head and neck squamous cell carcinoma

20. Myocardial Injury in Severe COVID-19 Compared With Non–COVID-19 Acute Respiratory Distress Syndrome

21. A panel of selected serum protein biomarkers for the detection of aggressive prostate cancer

24. Proteogenomic Characterization Reveals Therapeutic Vulnerabilities in Lung Adenocarcinoma

25. Proteogenomic Characterization of Endometrial Carcinoma

26. Integrated Proteogenomic Characterization of Clear Cell Renal Cell Carcinoma

27. Urinary glycoproteins associated with aggressive prostate cancer

32. Total, free and complexed PSA and hK2 for early detection of prostate cancer. (Cover Story)

34. Integrated Proteogenomic Characterization of Clear Cell Renal Cell Carcinoma

36. Changes in serum osteocalcin, plasma phylloquinone, and urinary gamma-carboxyglutamic acid in response to altered intakes of dietary phylloquinone in human subjects

37. Comparison of biochemical indexes for assessing vitamin K nutritional status in a healthy adult population

38. Re: Association Between Combined TMPRSS2:ERG and PCA3 RNA Urinary Testing and Detection of Aggressive Prostate Cancer

39. Identification of Serum Biomarker Panels for the Early Detection of Pancreatic Cancer.

40. Redesigned Proficiency Testing Materials Improve Survey Outcomes for Prostate-Specific Antigen

44. A Multi-Center Study of [−2]Pro-Prostate-Specific Antigen (PSA) in Combination with PSA and Free PSA for Prostate Cancer Detection in the 2.0 to 10.0 ng/mL PSA Range

46. proPSA Measurements in Serum and Tissue are Associated with Treatment Necessity Among Men Enrolled in Expectant Management for Prostate Cancer

48. Abstract 1268: Accurate measurement of serum total and free PSA using immunoaffinity depletion coupled to SRM: Correlation with clinical immunoassays

50. Fifth-Generation Digital Immunoassay for Prostate-Specific Antigen by Single Molecule Array Technology

Catalog

Books, media, physical & digital resources